Jump to content
IndiaDivine.org

J Gene: gene therapy pharmaceutics

Rate this topic


Guest guest

Recommended Posts

Controllable gene therapy Pharmaceutics of non-viral gene delivery systems

Tomlinson, E.1; Rolland, A.P.1

 

 

GeneMedicine, Inc., 8301 New Trails Drive, The Woodlands, TX 77381-4248, USA

Although most research on gene therapy has focused on the development of viral-mediated approaches to deliver therapeutic genes to cells both ex vivo and in vivo, non-viral gene medicines have emerged as a potentially safe and effective gene therapy method for the treatment of a wide variety of acquired and genetic diseases. Gene medicines consist of both a gene expression system that contains a therapeutic gene and a synthetic gene delivery system. Gene expression systems can be constructed to control the location, amount and duration of in vivo production of a therapeutic protein. A gene delivery system controls the distribution and access of a gene expression system to a target tissue, its recognition by cell-surface receptors and its intracellular trafficking. As each biological target will require a unique gene delivery and gene expression system, many of the principles and methods established in developing advanced drug delivery systems can be

applied to the design and preparation of synthetic gene delivery systems. This paper describes different approaches taken to protect and to enhance the delivery of gene expression systems to target cells. Self-assemblies of condensing carriers, such as cationic liposomes, synthetic polymers and peptides, with a gene expression system are described. The characterization of the resulting particulate gene medicines is reported, as is the influence of their physicochemical properties on the efficiency of gene delivery. This contribution also describes approaches to effect the intracellular trafficking of a gene expression system to the nucleus of a target cell, in particular by using synthetic amphipathic peptides to control the endosomal release of plasmid DNA.

Keywords: Non-viral gene therapy; Controllable gene therapy; Gene expression system; Gene delivery system; Liposome; Dendrimer; Fusogenic peptide

Gene, Volume 345, issue 1 (January 17, 2005), p. 119-126

ISSN: 0378-1119, DOI: 10.1016/j.gene.2004.11.034Elsevier Science

â—„ | â–º [ PDF Full Text] [ HTML Full Text]

Luggage? GPS? Comic books?

Check out fitting gifts for grads at Search.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...